Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Other Non-Current Liabilities (2018 - 2025)

Neurogene's Other Non-Current Liabilities history spans 5 years, with the latest figure at $428000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 40.39% year-over-year to $428000.0; the TTM value through Dec 2025 reached $428000.0, down 40.39%, while the annual FY2025 figure was $428000.0, 40.39% down from the prior year.
  • Other Non-Current Liabilities reached $428000.0 in Q4 2025 per NGNE's latest filing, roughly flat from $427000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.0 million in Q4 2023 to a low of $51000.0 in Q2 2024.
  • Average Other Non-Current Liabilities over 3 years is $408111.1, with a median of $427000.0 recorded in 2025.
  • The largest YoY upside for Other Non-Current Liabilities was 737.25% in 2025 against a maximum downside of 40.39% in 2025.
  • A 3-year view of Other Non-Current Liabilities shows it stood at $1.0 million in 2023, then fell by 28.63% to $718000.0 in 2024, then plummeted by 40.39% to $428000.0 in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Other Non-Current Liabilities are $428000.0 (Q4 2025), $427000.0 (Q3 2025), and $51000.0 (Q2 2025).